GeoVax Labs Inc (GOVX)

[remind2]

GOVX: AIDS vax Fed milestone $$ due. $7.6M owed.

The total FED cash due according to the news release in July, 2016 was $7.8M dollars.

GOVX got an immediate $199,000 to set up the human vaccine trials that were pending at that time. The rest of the cash is deliverable in milestone payments.

Yesterday, GOVX in a news release about World AIDS day let it be known that the human vaccinations are about to begin.

That will.or already has triggered the milestone payment due.

Likely, that $$ due are in the seven figures.

The news release will be big news because GOVX is valued at a miniscule $3.2M dollars.

The bigger benefit, of course , will be enormous free press.

So, Owning GOVX now, pre-AIDS news, is a pretty good idea.

News: 12/1/2016:
http://www.geovax.com/news-events/entry/2016/12/01/geovax-observes-world-aids-day.html

GeoVax is committed to an AIDS-free generation through vaccine development. Our HIV vaccine candidate is currently progressing through human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). To learn more about our work to fight HIV, visit www.geovax.com.


News release: $7.8M grant:
http://www.geovax.com/news-events/entry/2016/08/02/geovax-awarded-nih-contract-for-up-to-7-8-million-to-manufacture-hiv-vaccine-for-advanced-human-clinical-trials.html